<DOC>
	<DOCNO>NCT00138294</DOCNO>
	<brief_summary>The main purpose study learn influenza vaccine ( live attenuate inactivated influenza vaccine ) , give school-aged child 4 18 year age , stop lessen influenza ( flu ) outbreak community . Another purpose show vaccination child significantly reduce breathe problem ( vaccinated child unvaccinated people come contact community ) require visit doctor treatment . Another purpose continue collect safety flu protection information live attenuate influenza vaccine ( LAIV FluMist ) give child . The study investigator believe vaccination healthy school-aged child effective plan prevent many people community catch flu . Children take part study 5 10 month .</brief_summary>
	<brief_title>Control Epidemic Influenza Through School-based Influenza Vaccination Program</brief_title>
	<detailed_description>In renewal application ( 2008-2012 ) , study goal control epidemic influenza active immunization healthy school-aged child cold-adapted , trivalent , live , attenuated influenza vaccine ( LAIV ) at-risk child inactivate influenza vaccine ( IIV ) school-based vaccination program . The hypothesis universal vaccination healthy school-aged child alternative effective strategy control epidemic influenza , serve model control pandemic influenza biodefense . The specific aim study : control spread influenza susceptible adult 35 year age old vaccination school-aged child 4-18 year age ; control spread influenza susceptible child young adult le 35 year age vaccination school-aged child 4-18 year age ; develop school-based vaccination program rapid timely delivery LAIV IIV child 4-18 year age ; demonstrate school-aged child direct total effectiveness influenza vaccine reduce rate medically attend acute respiratory illness ( MAARI ) LAIV IIV recipient influenza epidemic ; capture safety information LAIV post-licensure . This open-label , four year community-based study . In first three study year , school-aged child ( 4 18 year age ) receive medical care Scott &amp; White Clinics ( SWCs ) , Temple-Belton area , Texas , ask participate study . Study participant receive LAIV IIV accord health status . Other child Temple-Belton area receive medical care SWC invite participate study may receive LAIV IIV . A comparable population enrol SWCs Waco/McLennan County area Bryan/College Station serve comparison group . In fourth final year study , LAIV provide study . However , influenza surveillance continue MAARI data collect assess continued protective benefit influenza vaccine . The final year also devote completion data analysis preparation manuscript . Children 4 year 8 year previously vaccinate influenza vaccine offer second dose 4 6 week first dose . The influenza vaccine contain three influenza virus strain choose FDA . Each subject receive nasal spray 0.2 ml dose ( 0.1 ml nostril ) LAIV 0.5 ml intramuscularly . The duration study year approximately five ten month , time enrollment ( August January , discretion investigator ) depend vaccine availability time influenza activity , end influenza season ( May ) .</detailed_description>
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>sign informed consent form adult participant parent/ legal guardian able understand comply protocol assent appropriate ( usually age great equal 7 year ) healthy subject , 4 18 year age none exclusion criterion history hypersensitivity , especially anaphylactic reaction , component FluMist™ , include egg egg product aspirin therapy aspirincontaining therapy history GuillainBarré syndrome know suspect immune deficiency disease combine immunodeficiency , agammaglobulinemia , thymic abnormality condition human immunodeficiency virus infection , malignancy , leukemia lymphoma immunosuppressive therapy systemic corticosteroid , alkylating drug , antimetabolite , radiation close contact within 21 day vaccination immunocompromised individual history asthma reactive airway disease history chronic underlying disease license inactivated flu vaccine ( IIVT ) recommend chronic disorder cardiovascular pulmonary system , chronic condition metabolic disease , renal dysfunction hemoglobinopathy require medical followup hospitalization precede year concurrent use antiinfluenza compound pregnant plan become pregnant within 42 day vaccination nursing mother condition , opinion investigator , interfere evaluation vaccine</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>March 2010</verification_date>
	<keyword>influenza vaccine</keyword>
	<keyword>live attenuate influenza vaccine ( LAIV FluMist )</keyword>
	<keyword>inactivate influenza vaccine ( IIV )</keyword>
	<keyword>School-based influenza vaccination program</keyword>
	<keyword>child</keyword>
	<keyword>herd protection</keyword>
</DOC>